BMC Cancer
Journal Abbreviation: BMC CANCER
ISSN: 1471-2407
Publisher: BioMed Central
Publications (98)
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study (2019)
Wallwiener M, Nabieva N, Feisst M, Fehm T, De Waal J, Rezai M, Baier B, et al.
Journal article
Dissecting TSC2-mutated renal and hepatic angiomyolipomas in an individual with ARID1B-associated intellectual disability (2019)
Popp B, Agaimy A, Kraus C, Knaup K, Ekici AB, Uebe S, Reis A, et al.
Journal article
Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma (2019)
Krueckel A, Moreira A, Froehlich W, Schuler G, Heinzerling L
Journal article
Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients (2019)
Rot S, Kaune T, Taubert H, Greither T, Kotrba J, Guettler A, Wichmann H, et al.
Journal article
Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme (2019)
Heynckes S, Daka K, Franco P, Gaebelein A, Frenking JH, Doria-Medina R, Mader I, et al.
Journal article
Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors (2019)
Dromain C, Pavel ME, Ruszniewski P, Langley A, Massien C, Baudin E, Caplin ME
Journal article
Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: A single center experience (2018)
Schelker RC, Herr W, Reichle A, Vogelhuber M
Journal article
A trend towards a more intense adjuvant treatment of low-grade-gliomas in tertiary centers in Germany after RTOG 9802 - results from a multi-center survey (2018)
Straube C, Kessel KA, Schmidt-Graf F, Krieg SM, Meyer B, Gempt J, Combs SE
Journal article
Moving targets in 4D-CTs versus MIP and AIP: Comparison of patients data to phantom data (2018)
Borm KJ, Oechsner M, Wiegandt M, Hofmeister A, Combs SE, Duma MN
Journal article
Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects (2018)
Munker S, Gerken M, Fest P, Ott C, Schnoy E, Fichtner-Feigl S, Wiggermann P, et al.
Journal article